Has offshore drug production and testing finally caught up with us? On Jan 23, 2015, the European Medicines Agency (EMA) recommended pulling four dozen generic drugs because they were approved based on flawed clinical studies conducted in India. A French inspection of GVK Biosciences in India revealed that “data manipulations of electrocardiograms during the conduct of some studies of generic medicines,” occurred for 5 years. Learn more.
